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Table 1
Characteristics of the Patients
Variable Number of
Patients
Gender
Female 67
Male 115
Diagnosis
Acute Leukemia 93
Chronic leukemia 48
Bone Marrow Failure 31
Lymphoma 5
Multiple Myeloma 4
Severe Combined
Immune Deﬁciency
1
Donor
Related 158
Unrelated 24
HSC Source
Bone Marrow 65
Peripheral Blood 109
Bone Marrow+ Peripheral
Blood
3
Umbilical Cord Blood 5
Conditioning Regimen
With Cy 174
Without Cy 8
Table
Donor source and infection risk (multivariate analysis)
Hazard ratio for UCB
vs. BM/PBSC (95% CI)
P-Value
Any infection 3.2 (2.3-4.4) <0.001
Bacterial 3.9 (2.8-5.5) <0.001
Viral 1.8 (1.1-2.7) 0.01
Fungal 2.7 (1.1-6.5) 0.03
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Infection is a major source of morbidity and mortality in
patients undergoing allogeneic hematopoietic cell trans-
plantation (HCT). Umbilical cord blood (UCB) recipients
appear to be at increased risk, and strategies to better
identify and mitigate infection are needed. To investigate
patterns and risk factors for infections by graft source (UCB
vs. bonemarrow (BM) or peripheral blood stem cells [PBSC]),
we conducted a single center retrospective study of 308
consecutive adult allogeneic HCT recipients transplanted
between 2006 - 2011 (BM 156, PBSC 103, UCB 49 patients).
All documented and presumed infections during the ﬁrst
year post-HCT were reviewed by a single reviewer. Among
BM/PBSC recipients, 53% received HCT using an unrelated
donor. Median age for UCB and BM/PBSC groups was 50 and
51 years. Diagnosis and disease status, HCT-CI scores, per-
formance status, and conditioning regimen intensity were
comparable among the two groups. Median time to neutro-
phil recovery (>500/mL) was 27 days in UCB and 13 days in
BM/PBSC recipients. The median length of transplant hos-
pitalization was 46 and 30 days, respectively. Bacterial in-
fections were more common for CB recipients (94% vs. 63%, P
< 0.001), without signiﬁcant differences in viral, fungal, or C.
difﬁcile infections. The day of ﬁrst infection was notably
earlier in the UCB recipients (median 6 vs. 30 days, P <
0.001), and >1 infection (bacterial, viral or fungal) occurred
in 65% of UCB vs. 34% of BM/PBSC recipients. Incidences of
acute and chronic GVHD were similar between groups,
however CB recipients were less likely to have GVHD prior to
diagnosis of bacterial (11% vs. 35%, P < 0.001) or viral infec-
tion (36% vs. 59%, P ¼ 0.03). On multivariate analysis, UCB
donor source remained a signiﬁcant risk factor prognostic for
all infection types (Table). Bacterial infection was associated
with increased mortality (HR 2.92, P < 0.001), as was fungal
infection (HR 2.58, P < 0.001), but not viral infection/reac-
tivation. In conclusion, UCB recipients have increased risk of
infections compared to BM/PBSC. Infections occurred earlier
and before engraftment in UCB recipients, suggesting the
role of factors other than prolonged neutropenia in their
pathogenesis. The association of donor source and post-HCT
infections is likely multifactorial.Ablative 164
Reduced intensity 18
Response
Complete Remission 147
Partial Remission 4
Not assessed 31
HC
Grade 1 83
Grade 2 43
Grade 3 42
Grade 4 14290
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Hemorrhagic cystitis is one of the important causes of
morbidity, which may occur after allogeneic hematopoietic
stem cell transplantation (allo-HSCT). Using high dose
cyclophosphamide (Cy) as the conditioning regimen is
associated with early-onset hemorrhagic cystitis (HC). It is
reported that the administration of mesna protects against
early-onset HC, caused by Cy. However, late-onset HCmay be
seen frequently due to viral infections, mostly cytomegalo-
virus (CMV) and BK/JC virus.
We have retrospectively analyzed 182 patients, who devel-
oped HC after allo-HSCT, from 1988 to 2013. Characteristics
of the patients were shown in Table 1.
We also present 44 HC patients having detailed data between
2010 and 2013. In these 44 patients median date of the
development of HC was calculated as 46 days (4-144). We
deﬁned early-onset HC is HCwhen developed before the 21st
day of HSCT, which consists of 7 patients and late-onset HC is
HC when developed afterwards of the 21st day of HSCT,
which consists of 37 patients. Graft versus Host Disease and
HC developed simultaneously in 28 patients.
Patients were initially treated with intravascular hydration
and constant bladder irrigation. This treatment was effective
within most of the patients. The treatment failed in 11 cases
and 5 of them underwent a cystoscopy for evacuation of
blood clots. Two patients infected with CMV and 9 patients
Table 2
Cases with refractory to initial treatment
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 Case 10 Case 11
HC Grade 3 3 3 3 1 2 3 1 3 2 3
Infection Factor BK virus BK+JC virus BK virus BK virus BK+ CMV CMV BK virus BK virus BK virus BK virus BK virus
Onset of HC Treatment Late Late Late Late Late Early Late Early Late Late Late
Hydration + + + + + + + + + + +
Cidofovir + + + + - - + - - + +
Ribavirin - + + + - - - - - - -
Ganciclovir + + - - - - -
Constant Bladder - - + - + - +
Irrigation + + + +
Hematoma - - - - - - +
Discharge - + + +
Selective
embolization of - - - - - - -
vesical artery - - - +
Overall Response no no yes no yes yes no yes no yes yes
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cidofovir (ribavirin), respectively. The treatment has failed
in 3 of 9 patients and all of them have died due to accom-
panying infections. One patient also underwent selective
embolisation of vesical artery (Table 2).
As a result, early-onset HC is related to Cy, but late-onset HC
is usually associated with BK or CMV infections. HC is
generally well treated with i.v hydration and bladder irri-
gation. In some cases antiviral drugs could be needed. Also,
resistant cases may be observed and mortality may be seen
due to HC. It is important that the team, who perform allo-
HSCT, should be prepared for morbidity due to HC and
multidisciplinary treatment algorithm should be designed
which includes cooperation with urology and interventional
radiology clinics.291
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Purpose: While the beneﬁts of exercise interventions in
people undergoing HCT have been systematically reviewed
elsewhere, subject attrition rates and adherence to exercise
interventions following HCT have not. This systematic review
of the literature examined subject attrition rates and reasons
for attrition as well as adherence to exercise interventions
following BMT/HCT.
Methods: Publications were identiﬁed through literature
searches of PubMed, CINAHL, and Embase as well as hand
searching the references of retrieved studies. Studies pub-
lished between January 1985 and July 2013 that prospec-
tively tested an exercise intervention in BMT/HCT patients
were included. All retrieved abstracts were initially classiﬁed
as (1) exercise intervention studies; (2) studies related to
exercise and/or BMTor HCT that did not prospectively test an
exercise intervention; (3) integrative or systematic reviews
of exercise intervention studies in BMT or HCT patients; or,
(4) other types of reviews articles (i.e., clinical reviews, case
reports, etc.). Studies that prospectively tested an exercise
intervention were further evaluated to determine (1) the
type of exercise modality employed; (2) subject attrition
rates and reasons for attrition; (3) the amount of supervision
required to implement the intervention; (4) timing of the
intervention; and, (5) exercise adherence rates.
Results: Twenty studies met the inclusion criteria. The ma-
jority of studies tested an aerobic exercise intervention (n¼7;35%) or a combination of aerobic and strength training (n¼7;
35%). The aerobic exercise interventions varied and included
activities such as stationary bicycling, walking, or treadmill
walking. Other exercise modalities tested included: (1)
strength training (n¼4; 20%) or (2) combination of stretch-
ing, aerobic and strength training (n¼2; 10%). Supervised
exercise sessions (55%; n ¼ 11) were more commonly used
than unsupervised sessions (20%; n¼ 4). Five studies (25%)
used a combination approach by supervising some sessions
with study participants completing other sessions unsuper-
vised. The overall attrition rate was 18% (180/998 subjects).
Major reasons for attrition included death, change in health
status, protocol issues, personal issues, and lost to follow-up/
no reason provided. Supervised exercise programs rarely
published exercise adherence information. Unsupervised
exercise program relied mainly on self-report to document
adherence. Adherence rates in these studies ranged from 50-
100%.
Conclusion: Questions regarding subject attrition and
adherence to exercise interventions must be addressed to
identify those interventions that are likely to be successful
when translated into clinical practice. Subject attrition from
exercise studies following BMT/HCT is relatively low.
Adherence information for exercise interventions needs to
be regularly addressed.292
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Introduction: Oral mucositis (OM) is a common, debilitating
complication of conditioning regimens for hematopoietic
stem cell transplantation (HSCT). Supersaturated calcium
phosphate rinse (SCPR) and palifermin have shown efﬁcacy
in preventing OM. However, whether their efﬁcacy differs is
unknown. We compared the efﬁcacy of SCPR and palifermin
in HSCT patients receiving myeloablative conditioning.
Methods: A comprehensive review of our institutional
database was performed to identify patients who received
myeloablative-conditioning between 2008 and 2012. Two
cohorts were identiﬁed and analyzed separately. All patients
in the ﬁrst cohort received 400 cGy of total body irradiation
and the majority received Fludarabine 250 mg/m2 and
